Facultad de Medicina (FM)
Centro académico
Hospital Costa Del Sol
Marbella, EspañaPublicacións en colaboración con investigadores/as de Hospital Costa Del Sol (40)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
2023
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031
-
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
Journal of Medical Virology, Vol. 95, Núm. 12
2022
-
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781
2021
-
A facility and community-based assessment of scabies in rural Malawi
PLoS neglected tropical diseases, Vol. 15, Núm. 6, pp. e0009386
-
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Nature, Vol. 589, Núm. 7842, pp. 448-455
-
Glomerular diseases in diabetic patients: Implications for diagnosis and management
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Leukemia, Vol. 35, Núm. 1, pp. 245-249
-
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Blood Cancer Journal, Vol. 11, Núm. 5
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
-
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
British Journal of Cancer, Vol. 124, Núm. 6, pp. 1138-1149
-
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Blood, Vol. 138, Núm. 17, pp. 1583-1589
2020
-
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Drug Resistance Updates, Vol. 53
-
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)
Journal of Infection, Vol. 81, Núm. 4, pp. 600-606
2019
-
Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
OncoImmunology, Vol. 8, Núm. 7
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
-
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity
Cell Stress, Vol. 3, Núm. 7, pp. 236-239
-
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Nature, Vol. 569, Núm. 7756, pp. 428-432
2018
-
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Annals of Oncology, Vol. 29, Núm. 10, pp. 2121-2128